...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Whole-brain Radiation Therapy for Breast Cancer Patients with Dural Metastasis Without Concomitant Brain Metastasis and Leptomeningeal Metastasis
【24h】

Whole-brain Radiation Therapy for Breast Cancer Patients with Dural Metastasis Without Concomitant Brain Metastasis and Leptomeningeal Metastasis

机译:乳腺癌患者的全脑放射治疗无伴随脑转移和Leptomenenal Metastasis

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To evaluate outcomes of breast cancer patients with confirmed dural metastasis (DM) alone who received whole-brain radiation therapy (WBRT). Patients and Methods: The medical records of thirty-three breast cancer patients who received WBRT to treat intracranial metastasis were retrospectively reviewed. The clinical presentation of DM-only was compared with that of brain metastasis (BM)/leptomeningeal metastasis (LM). Results: Eight patients had DM and 25 patients had BM/LM. Median survival was 12 months in patients with DM and 7 months in those with BM/LM. Multivariate analysis found that only a Karnofsky performance status of = 70 was significantly associated with improved OS. DM did not cause the death of any patient. Symptoms did not worsen in any DM patient. Conclusion: WBRT can be considered for patients with DM alone for symptom improvement and preventing DM-related death.
机译:目的:评估乳腺癌患者的乳腺癌患者的结果,确认的多云转移(DM)接受全脑放射治疗(WBRT)。 患者及方法:回顾性审查了接受WBRT治疗颅内转移的三十三名乳腺癌患者的病态。 DM-POPLE的临床介绍与脑转移(BM)/ Leptomeneneal转移(LM)进行了比较。 结果:8名患者患有DM和25名患者的BM / LM。 中位数生存率为12个月,患者在DM和7个月内患有BM / LM。 多变量分析发现,只有Karnofsky的性能状态& = 70显着与改进的操作系统有显着相关。 DM没有导致任何患者的死亡。 症状在任何DM患者中都不会恶化。 结论:单独DM患者可以考虑WBRT用于症状改善和预防DM相关死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号